Meeting the Challenges in Atrial Fibrillation Management: The Role of New Anticoagulants

Chairpeople:

Freek Verheugt , ¹ Christoph Bode ²

Speakers:

Gregory Lip , ³ Raffaele De Caterina , ⁴ Robert Giugliano ⁵

1. Heart Lung Centre, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
2. Heart Center Freiburg University, Freiburg, Germany
3. University of Birmingham, Birmingham, UK
4. “G. d’Annunzio” University, Chieti, Italy
5. Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

Acknowledgements:

Writing assistance provided by Dr Saroshi Amirthalingam, apothecom scopemedical Ltd.

Citation:

EMJ Cardiol. 2014;2:38-45. DOI/10.33590/emjcardiol/10311237. https://doi.org/10.33590/emjcardiol/10311237.

Support:

The publication of this article was funded by Daiichi Sankyo Europe GmbH. The views and opinions expressed are those of the authors and not necessarily of Daiichi Sankyo.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.